Drug Cotazym From Organon Usa Inc With Pancrelipase (amylase;lipase;protease) 30,000usp Units;8,000usp Units;30,000usp Units

The Ingredients: Pancrelipase (amylase;lipase;protease)
Dosage Form and Administration: Capsule; Oral
Drug Trade Name: Cotazym
Firm: Organon Usa Inc
Strength: "30,000USP UNITS;8,000USP UNITS;30,000USP UNITS"
New Drug Application Type: N
The Drug Application Number:20580
Medicine Product Number: 1
Approval Date: 12/9/1996
Reference Listed Drug: No
Type: DISCN
Applicant Full Name: Organon Usa Inc

Skin Tag

A skin tag is a common, benign condition that consists of a bit of skin which projects from the surrounding skin and may appear attached to the skin. Skin tags can vary quite a bit in appearance. They may be smooth or irregular, flesh colored or more deeply pigmented, and either simply be raised above the surrounding skin or have a stalk so that the skin tag hangs from the skin. Americans spend billions of dollars each year on skin care products that promise to erase wrinkles, lighten age spots and eliminate itching, flaking or redness. Yet, the simplest and cheapest way to keep skin healthy and young looking is to stay out of the sun. Sunlight is a major cause of the skin changes we think of as aging--changes such as wrinkles, dryness and age spots. The skin does change as it ages. For example, with age, people sweat less, leading to increased skin dryness. As the skin ages, it becomes thinner and loses fat, so it looks less plump and smooth. Underlying structures--veins and bones in particular--become more prominent. Skin can take longer to heal when injured.

Drug Abuse Treatment for Criminals

Drug abuse treatment is an effective intervention for drug abusers, including those who are involved with the criminal justice system. However, the effectiveness of drug treatment depends on both the individual and the program and on whether interventions and treatment services are available and appropriate for the needs of the individual. To amend attitudes, beliefs and behaviors that support drug use, the drug abuser must engage in a therapeutic change process. Longitudinal outcome studies find that those who participate in drug abuse treatment programs in the community commit fewer crimes than those who do not participate.
A history of drug use does not indicate the need for drug abuse treatment. Offenders who meet drug dependence criteria should have higher priority for treatment than those who do not. Less intensive interventions, such as drug abuse education or self help participation, may be appropriate for those not meeting criteria for drug dependence.
Some drug abuse treatments programs tailor to the needs of juveniles. Some programs offer psychiatric treatment. All drug abuse treatment programs become more effective when criminal or cognitive behavioral criminal justice personnel work in tandem with treatment providers.
If drug abusers meet other criteria, low motivation to participate in treatment or to end drug abuse should not preclude access to treatment. Motivational enhancement interventions may be useful in these cases. Examples of motivation include motivational interviewing and contingency management techniques, which often provide tangible rewards.

Offender Legal Pressures

Legal pressure that encourages abstinence and treatment participation may also help individuals by improving retention and catalyzing longer treatment stays.
Drug abuse treatment is effective for offenders who have a history of serious and violent crime, particularly with intensive, targeted services. The economic benefits in avoided crime and costs to crime victims, like medical costs, lost earnings and loss in quality of life, may be substantial for these higher risk offenders. Treating them requires a high degree of coordination between drug abuse treatment providers and criminal justice personnel in order to ensure that the treatment and criminal genic meet the needs of the individual.